drugset / Trial / NCT01609855

Does the Hyoscine N-Butylbromide Administered During Colonoscopy Increase the Adenoma Detection Rate?

NCT01609855

Phase 4 Unknown 400 enrolled Valduce Hospital
RandomizedParallel-groupDouble-blindDiagnostic

Summary

The primary aim of the study was to test if the administration of Hyoscine Butyl Bromide, at time of caecal intubation, increases the adenoma detection rate.

Timeline

Start
2012-01
Primary completion
2012-06
Completion
2012-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Hyoscine butylbromide Unknown 20 mg Intravenous

Indications